NO20065064L - Vaksine for tannsykdommer - Google Patents

Vaksine for tannsykdommer

Info

Publication number: NO20065064L
Authority: NO; Norway
Prior art keywords: periodontal disease; vaccine; disease; methods; treating
Prior art date: 2004-05-21

Application number

NO20065064A

Other languages

English (en)

Norwegian (no)

Inventor

John Morgan Hardham

Rajendra Krishnan

David Ross Mcgavin

Kimberly Jean Dreier

John David Haworth

Kenndall Wayne King

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-21

Filing date

2006-11-02

Publication date

2006-12-01

2006-11-02 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-12-01 Publication of NO20065064L publication Critical patent/NO20065064L/no

Links

229960005486 vaccine Drugs 0.000 title abstract 3
208000018035 Dental disease Diseases 0.000 title 1
208000014151 Stomatognathic disease Diseases 0.000 title 1
208000028169 periodontal disease Diseases 0.000 abstract 3
108091033319 polynucleotide Proteins 0.000 abstract 3
102000040430 polynucleotide Human genes 0.000 abstract 3
239000002157 polynucleotide Substances 0.000 abstract 3
229920001184 polypeptide Polymers 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
108020004465 16S ribosomal RNA Proteins 0.000 abstract 1
241000894006 Bacteria Species 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Fodder In General (AREA)
Peptides Or Proteins (AREA)

NO20065064A 2004-05-21 2006-11-02 Vaksine for tannsykdommer NO20065064L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/851,965 US7378101B2 (en)	2001-12-21	2004-05-21	Vaccine for periodontal disease
PCT/IB2005/000822 WO2005112993A1 (en)	2004-05-21	2005-03-21	Vaccine for periodontal disease

Publications (1)

Publication Number	Publication Date
NO20065064L true NO20065064L (no)	2006-12-01

Family

ID=35058733

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20065064A NO20065064L (no)	2004-05-21	2006-11-02	Vaksine for tannsykdommer

Country Status (19)

Country	Link
US (2)	US7378101B2 (de)
EP (1)	EP1753454B1 (de)
JP (1)	JP4099213B2 (de)
CN (1)	CN101014363A (de)
AR (1)	AR048347A1 (de)
AT (1)	ATE432082T1 (de)
AU (1)	AU2005244663A1 (de)
BR (1)	BRPI0510148A (de)
CA (1)	CA2565925C (de)
DE (1)	DE602005014635D1 (de)
ES (1)	ES2325737T3 (de)
IL (1)	IL178971A0 (de)
MX (1)	MXPA06013471A (de)
NO (1)	NO20065064L (de)
NZ (1)	NZ550981A (de)
RU (1)	RU2364417C2 (de)
TW (1)	TW200538152A (de)
WO (1)	WO2005112993A1 (de)
ZA (1)	ZA200609105B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8129500B2 (en) *	1997-12-10	2012-03-06	Csl Limited	Porphyromonas gingivalis polypeptides and nucleotides
US7378101B2 (en) *	2001-12-21	2008-05-27	Pfizer, Inc.	Vaccine for periodontal disease
US7682619B2 (en)	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
US9181592B2 (en) *	2007-03-30	2015-11-10	Case Western Reserve University	Method for detecting a bacterial pathogen
WO2008137506A2 (en) *	2007-05-01	2008-11-13	Mars Incorporated	Methods and kits for dog plaque disease
JP2009173558A (ja) *	2008-01-22	2009-08-06	Gen Corp:Kk	抗イヌ歯周病組成物
US8691502B2 (en)	2008-10-31	2014-04-08	Tremrx, Inc.	T-cell vaccination with viral vectors via mechanical epidermal disruption
UA107940C2 (en) *	2009-09-10	2015-03-10	Merial Ltd	The vaccine composition that includes the saponin-containing adjuvant
BR112012012921A2 (pt) *	2009-12-01	2016-10-25	Intervet Int Bv	uso de uma quantidade imunogênica de um vírus da doença de newcastle inativado e um adjuvante, composição farmacêutica, e, kit de partes
WO2012151272A2 (en) *	2011-05-02	2012-11-08	Tremrx, Inc.	T-cell vaccination with viral vectors via mechanical epidermal disruption
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
WO2013089166A1 (ja) *	2011-12-13	2013-06-20	学校法人麻布獣医学園	Porphyromonas gulaeの線毛タイプ
US9347065B2 (en)	2012-03-29	2016-05-24	International Aids Vaccine Initiative	Methods to improve vector expression and genetic stability
JPWO2015190589A1 (ja) *	2014-06-13	2017-04-20	学校法人麻布獣医学園	イヌの僧帽弁閉鎖不全症のリスク診断
JP2018154574A (ja) *	2017-03-16	2018-10-04	合同会社チューモス	点眼ワクチン及び免疫誘導方法
SG11202003147XA (en)	2017-10-12	2020-05-28	Vaxcyte Inc	Periodontitis vaccine and related compositions and method of use
WO2020141103A1 (en)	2018-12-31	2020-07-09	Bellevacc As	Bacterial vaccine
WO2021001986A1 (ja)	2019-07-04	2021-01-07	株式会社ソーシン	動物用の口腔用組成物並びにそれを使用した動物用の歯周病予防剤、感染症予防剤及び口臭予防剤
US10973908B1 (en)	2020-05-14	2021-04-13	David Gordon Bermudes	Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en)	2020-07-22	2026-01-27	David Gordon Bermudes	Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
CN116751292B (zh) *	2023-07-31	2024-05-14	河南大学	牙龈卟啉单胞菌Mfa1单克隆抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59128338A (ja) *	1982-12-08	1984-07-24	Kitasato Inst:The	歯周炎予防用ワクチン及びその製法
JPH0662431B2 (ja)	1984-12-14	1994-08-17	ライオン株式会社	歯周炎予防用経口ワクチン
US5536497A (en) *	1992-12-21	1996-07-16	The Research Foundation Of State University Of New York	Fimbrial polypeptides useful in the prevention of periodontitis
JPH0797395A (ja)	1993-09-28	1995-04-11	Kyowa Medex Co Ltd	ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
EP0726314A4 (de)	1993-10-08	1998-04-22	Lion Corp	FIMBRILLINPROTEIN AUS -i(PORPHYROMONAS GINGIVALIS)
US5563063A (en)	1995-08-30	1996-10-08	Nihon University (Educational Foundation)	Porphyromonas crevioricanis species of microorganism
US5710039A (en)	1995-08-30	1998-01-20	Nihon University (Educational Foundationn)	Porphyromonas gingivicanis strain ATCC 55562
AUPQ137699A0 (en) *	1999-07-02	1999-07-22	University Of New England, The	Control of acidosis
AUPQ718200A0 (en)	2000-04-28	2000-05-25	Csl Limited	Porphyromonas gingivalis recombinant proteins and truncations
US7378101B2 (en) *	2001-12-21	2008-05-27	Pfizer, Inc.	Vaccine for periodontal disease
US7468185B2 (en) *	2001-12-21	2008-12-23	Pfizer Inc.	Vaccine for periodontal disease

2004
- 2004-05-21 US US10/851,965 patent/US7378101B2/en not_active Expired - Fee Related
2005
- 2005-03-21 MX MXPA06013471A patent/MXPA06013471A/es active IP Right Grant
- 2005-03-21 WO PCT/IB2005/000822 patent/WO2005112993A1/en not_active Ceased
- 2005-03-21 DE DE602005014635T patent/DE602005014635D1/de not_active Expired - Lifetime
- 2005-03-21 NZ NZ550981A patent/NZ550981A/en not_active IP Right Cessation
- 2005-03-21 CN CNA2005800230182A patent/CN101014363A/zh active Pending
- 2005-03-21 CA CA2565925A patent/CA2565925C/en not_active Expired - Fee Related
- 2005-03-21 BR BRPI0510148-4A patent/BRPI0510148A/pt not_active IP Right Cessation
- 2005-03-21 EP EP05718305A patent/EP1753454B1/de not_active Expired - Lifetime
- 2005-03-21 ES ES05718305T patent/ES2325737T3/es not_active Expired - Lifetime
- 2005-03-21 JP JP2007517471A patent/JP4099213B2/ja not_active Expired - Lifetime
- 2005-03-21 AT AT05718305T patent/ATE432082T1/de not_active IP Right Cessation
- 2005-03-21 RU RU2006140984/13A patent/RU2364417C2/ru not_active IP Right Cessation
- 2005-03-21 AU AU2005244663A patent/AU2005244663A1/en not_active Abandoned
- 2005-03-30 AR ARP050101226A patent/AR048347A1/es not_active Application Discontinuation
- 2005-03-30 TW TW094109998A patent/TW200538152A/zh unknown
2006
- 2006-10-31 IL IL178971A patent/IL178971A0/en unknown
- 2006-11-01 ZA ZA200609105A patent/ZA200609105B/xx unknown
- 2006-11-02 NO NO20065064A patent/NO20065064L/no not_active Application Discontinuation
2008
- 2008-05-12 US US12/119,136 patent/US20080311151A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE432082T1 (de)	2009-06-15
JP2008500379A (ja)	2008-01-10
RU2364417C2 (ru)	2009-08-20
MXPA06013471A (es)	2007-01-23
DE602005014635D1 (de)	2009-07-09
US7378101B2 (en)	2008-05-27
CA2565925A1 (en)	2005-12-01
ES2325737T3 (es)	2009-09-15
TW200538152A (en)	2005-12-01
EP1753454B1 (de)	2009-05-27
WO2005112993A1 (en)	2005-12-01
RU2006140984A (ru)	2008-05-27
ZA200609105B (en)	2008-12-31
IL178971A0 (en)	2007-03-08
CA2565925C (en)	2011-01-18
JP4099213B2 (ja)	2008-06-11
NZ550981A (en)	2009-07-31
US20080311151A1 (en)	2008-12-18
AR048347A1 (es)	2006-04-19
CN101014363A (zh)	2007-08-08
US20050010032A1 (en)	2005-01-13
EP1753454A1 (de)	2007-02-21
AU2005244663A1 (en)	2005-12-01
BRPI0510148A (pt)	2007-10-02

Legal Events

Date	Code	Title	Description
2013-10-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20065064L (no)	2006-12-01	Vaksine for tannsykdommer
WO2003054755A3 (en)	2004-06-10	Vaccine for periodontal disease
DE60330041D1 (de)	2009-12-24	Methode um saatgut zu schützen, das mit phytotoxischen stoffen behandelt ist
UA84284C2 (ru)	2008-10-10	Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
NO20032944D0 (no)	2003-06-26	Styringssystem for kjemisk injisering samt fremgangsmåte for kjemisk injisering i flere brönner
ATE517094T1 (de)	2011-08-15	Verfahren zur herstellung von medetomidin und seinen salzen
WO2004083816A3 (en)	2005-04-14	Loss of heterozygosity of the dna markers in the 12q22-23 region
EP2528931A4 (de)	2013-12-04	Cyclovirus und verwendungsverfahren dafür
ITTO20020809A1 (it)	2004-03-18	Micropompa, in particolare per un dispositivo integrato di analisi del dna.
DE602005006502D1 (de)	2008-06-19	Druckverfahren, das eine entwicklungsfreie Druckplatte verwendet.
DK1622642T3 (da)	2008-03-25	E. Coli-fuglevaccine til beskyttelse mod colibacillose
WO2006046017A3 (en)	2006-09-14	Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter
IL172541A0 (en)	2006-04-10	2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosyliceramide synthase (gcs)
WO2006022619A3 (en)	2006-05-11	Methods for identifying risk of type ii diabetes and treatments thereof
DK1667523T3 (da)	2013-01-21	DNA-vaccinesammensætninger og fremgangsmåder til deres anvendelse
TW200517495A (en)	2005-06-01	Vaccine for periodontal disease
ITSV20030048A1 (it)	2005-06-12	Dispositivo elettromeccanico di comando in particolare per imbarcazioni.
DK1670498T3 (da)	2013-03-11	DNA, der koder for p185neu, og terapeutiske anvendelser deraf
WO2006046994A3 (en)	2009-04-09	Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk
BRPI0607473A2 (pt)	2009-09-08	infecção por helicobacter em suìnos
WO2005017176A3 (en)	2007-10-04	Methods for identifying risk of melanoma and treatments thereof
WO2006074061A3 (en)	2009-06-04	Methods for identifying risk of low bmd and treatments thereof
ITFI20020191A1 (it)	2004-04-10	Contenitore per analisi batteriologiche.
Zohreh et al.	2015	Association study of the TREM2 gene and identification of a novel variant in Exon 2 in Iranian patients with Late-Onset Alzheimer's disease
ITRM20030033A1 (it)	2003-04-28	Sistema di chiusura per autoclavi di estrazione in pressione.